AVITA Medical, Inc.
RCEL
$5.16
-$0.14-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.72% | -64.03% | -86.01% | -48.24% | -102.36% |
| Total Depreciation and Amortization | 156.65% | 118.72% | 89.02% | 39.73% | 50.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.32% | 194.38% | 163.43% | 77.62% | 17.60% |
| Change in Net Operating Assets | 103.86% | -24,966.67% | 181.27% | 84.68% | -87.26% |
| Cash from Operations | 50.59% | 25.61% | 19.61% | -40.42% | -129.96% |
| Capital Expenditure | 80.73% | -444.59% | -649.00% | -786.96% | -303.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.23% | 107.16% | -49.90% | -19.17% | -14.99% |
| Cash from Investing | -28.54% | 104.31% | -66.02% | -32.30% | -19.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -42.47% | 52.39% | 67.83% | 396.49% | 269.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.47% | -97.41% | 67.83% | 396.49% | 269.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.87% | 84.03% | -91.12% | -94.69% | -152.27% |